Loss-of-function (LOF) mutations in the endothelial cell (EC)-enriched gene endoglin (ENG) cause the human disease hereditary haemorrhagic telangiectasia-1, characterized by vascular malformations promoted by vascular endothelial growth factor A (VEGFA). How ENG deficiency alters EC behaviour to trigger these anomalies is not understood. Mosaic ENG deletion in the postnatal mouse rendered Eng LOF ECs insensitive to flow-mediated venous to arterial migration. Eng LOF ECs retained within arterioles acquired venous characteristics and secondary ENG-independent proliferation resulting in arteriovenous malformation (AVM). Analysis following simultaneous Eng LOF and overexpression (OE) revealed that ENG OE ECs dominate tip-cell positions and home preferentially to arteries. ENG knockdown altered VEGFA-mediated VEGFR2 kinetics and promoted AKT signalling. Blockage of PI(3)K/AKT partly normalized flow-directed migration of ENG LOF ECs in vitro and reduced the severity of AVM in vivo. This demonstrates the requirement of ENG in flow-mediated migration and modulation of VEGFR2 signalling in vascular patterning.
Loss-of-function (LOF) mutations in the endothelial cell (EC)-enriched gene endoglin (ENG) cause the human disease hereditary haemorrhagic telangiectasia-1, characterized by vascular malformations promoted by vascular endothelial growth factor A (VEGFA). How ENG deficiency alters EC behaviour to trigger these anomalies is not understood. Mosaic ENG deletion in the postnatal mouse rendered Eng LOF ECs insensitive to flow-mediated venous to arterial migration. Eng LOF ECs retained within arterioles acquired venous characteristics and secondary ENG-independent proliferation resulting in arteriovenous malformation (AVM). Analysis following simultaneous Eng LOF and overexpression (OE) revealed that ENG OE ECs dominate tip-cell positions and home preferentially to arteries. ENG knockdown altered VEGFA-mediated VEGFR2 kinetics and promoted AKT signalling. Blockage of PI(3)K/AKT partly normalized flow-directed migration of ENG LOF ECs in vitro and reduced the severity of AVM in vivo. This demonstrates the requirement of ENG in flow-mediated migration and modulation of VEGFR2 signalling in vascular patterning.
Development of the blood vasculature into a hierarchical network of arteries, capillaries and veins involves tip-cell selection, migration, proliferation, mural cell recruitment, fusion of sprouts (anastomosis), lumen formation, growth and pruning 1 . These vessel rearrangements rely on a precise coordinated behaviour of individual ECs to gain and sustain hierarchy and functionality, controlled by cell signalling and flow-mediated shear forces 2 . The initiation and formation of new branches, known as sprouting angiogenesis, is driven by VEGFA 3 and fine-tuned via the Jagged/Delta-like/Notch cascades [4] [5] [6] [7] [8] [9] . Interference with these systems results in vessel patterning defects [9] [10] [11] [12] [13] . One such defect is manifested by direct shunts between arteries and veins, so-called arteriovenous malformations (AVMs). LOF mutations in either ENG or ACVRL1 (activin receptor-like kinase 1, also known as ALK1) cause the human vascular diseases hereditary haemorrhagic telangiectasia (HHT) 1 and 2, respectively. HHT, also known as Osler-Weber-Rendu syndrome, is characterized by vessel patterning defects causing micro-aneurysms (telangiectases) with bleedings in skin and mucosal membranes, as well as AVMs in brain, lung and liver. Whether mechanisms of tip-stalk cell selection, EC migration and proliferation are intimately connected with AVM development remains to be determined.
Postnatal conditional EC-specific deletion of Eng or Alk1 in the mouse leads to development of AVMs, and represents valuable models of HHT. However, while Eng LOF has a mild hyperbranching phenotype, Alk1 LOF strongly promotes tip-cell potential as well as branching [14] [15] [16] . ENG and ALK1 are receptors involved in the transforming growth factor beta (TGFβ)/bone morphogenetic protein (BMP) pathway mediating downstream activation of the SMAD1/5/8 transcription factors 17 , which modulate vascular patterning 18 .
Observations in HHT1 patients and in genetic mouse models with Eng LOF indicate that AVMs are triggered by wounding and/or by VEGFA administration [19] [20] [21] [22] . Recent clinical trials utilizing VEGFA inhibition for treatment of HHT have highlighted the impact of VEGFA on promoting the establishment of AVMs 23, 24 . Despite these findings the functional link between VEGFA and ENG remains unknown. Also, how Eng deletion transmits into altered cellular behaviour resulting in AVM has been unresolved, as has the potential arterial/capillary/venous preference for AVM initiation. Here we describe the impact of Eng LOF on cellular behaviour in sprouting angiogenesis, vascular remodelling and AVM, involving an ENGmediated modulation of VEGFR2 signalling. We conclude that ENG cell-autonomously controls EC migration during vessel remodelling in response to VEGFA and shear stress; a process that is required for the establishment of arteriovenous vessel hierarchy. In Eng LOF mice, ECs fail to establish arteriole properties and instead acquire venous characteristics with secondary proliferation and expansion leading to AVM. Hence, arterioles are the main initial sites of malformation. In addition, our data functionally uncouple the processes of enhanced sprouting angiogenesis and AVM in HHT.
RESULTS
Postnatal EC-specific deletion of Eng causes primary AVM and secondary hypersprouting
Here we demonstrate that tamoxifen-induced EC-specific deletion of Eng at postnatal day (P) 1 in Eng flox/flox :Cdh5(PAC)CreER T 2 :R26Ryfp (henceforth denoted Eng i∆EC ) mice leads to local AVMs within the cerebral vasculature at P7 and at the same time promotes sprouting angiogenesis as indicated by the increase in angiogenic tip cells ( Fig. 1a-c) . Immunostaining revealed that the vast majority of YFPpositive cells had lost expression of ENG protein ( Supplementary  Fig. 1a ), confirming that conditional expression of YFP serves as a reliable marker for Eng deletion. Vegfa transcripts were 2.3-fold higher in whole brain lysates from Eng LOF pups compared with littermate controls, indicating reduced oxygen supply (Fig. 1d ). In accordance with previous studies, the retinal vasculature of Eng LOF mice displayed AVMs and reduced radial expansion 14 (Fig. 1e ). In retinas with large AVMs, areas with excessive sprouting correlated with local hypoxic regions as indicated by pimonidazole staining ( Supplementary Fig. 1b ). Also, deletion of Eng at P4 and analysis of P7 retinas revealed that local Eng deletion is insufficient to induce excessive sprouting and reduction in radial expansion, and that these phenomena rely on the presence of AVMs (Fig. 1e ). Furthermore, sporadic microvascular/glomeruloid tufts, composed of only wildtype (WT) cells appeared within the brain vasculature of Eng LOF mice when induced at P1 ( Supplementary Fig. 1c ). These findings suggest that enhanced sprouting and tuft formation are secondary to AVM and likely to be caused by a hypoxia-induced increase in VEGFA as a consequence of reduced vascular functionality.
Loss of Eng cell-autonomously suppresses tip-cell potential in competition with WT or ENG-overexpressing ECs
To further investigate the role of ENG in vascular morphogenesis we characterized its expression within the postnatal brain and retinal vasculature, where Eng was specific and abundant within the endothelium but strongly reduced in tip cells compared with stalk cells (Fig. 2a-c) . This was confirmed by Eng -lacZ reporter activity in Eng lacZ/wt mice at P7 ( Supplementary Fig. 2a,b) , establishing Eng as a stalk-cell-enriched gene. In addition, Eng expression was high in veins and arterioles but low in major arteries at P7 ( Supplementary Fig. 2b ). In adults the expression was further potentiated in ECs of arterioles that branch from the main arteries ( Supplementary Fig. 2c ).
The distinct differential tip-stalk expression of Eng in vivo suggested a role in tip-stalk selection, analogous to that of the ALK1 receptor 16, 25, 26 . To investigate this possibility, Eng i∆EC mice were treated with low-dose tamoxifen at P1 to induce cellular mosaicism for Eng deletion. Clonal analysis of Eng LOF cells in the mosaic sprouting vasculature of retinas at P7 revealed that they were under-represented in the sprouting front ( Fig. 2d,h) . Similar distribution was evident in the developing cerebral vasculature, where 60% of the tip cells were WT (YFP − ) and 40% Eng LOF cells (YFP + ) in Eng i∆EC mice compared with 51% (YFP − )/49% (YFP + ) cells in control mice ( Fig. 2e ,i). To uncouple the endogenous regulation of Eng, a transgenic mouse with conditional overexpression (OE) of human ENG (hENG, the mouse denoted Eng iECOE ) 27 was crossed with Eng i∆EC mice to generate Eng i∆EC+iOE . Due to different recombination efficiency of LOF and OE alleles, mosaic ENG OE could be studied in the background of complete Eng deletion ( Supplementary Fig. 3a ). In these mice, hENG OE cells were clearly overrepresented within the tip-cell population compared with Eng LOF cells in retina (86% versus 14%, Fig. 2f ,j) as well as cerebrum ( Fig. 2g,k) . These data suggest that ENG can act in a cell-autonomous manner to promote tip-cell competence. Downregulation of Eng in tip cells in the WT situation may hence function to limit sprout elongation and to facilitate anastomosis. To acquire transcriptional information from Eng LOF and WT cells within the same vasculature, a mouse with endothelial specific GFP expression (Claudin5-GFP, Supplementary Fig. 3b ) was crossed with Eng flox/flox mice carrying a conditional nuclear-localized fluorophore (R26R-H2B-mCherry). Comparison between sorted Eng LOF ECs and WT ECs from mosaic brains of the same mice ( Fig. 2l ) revealed no difference in the tip-cell-enriched genes Dll4 and Cxcr4 (Fig. 2m ). However, Id1, Hey1 and Ephrinb2 were downregulated in Eng LOF ECs, suggesting a shift towards a more venous identity ( Fig. 2m) . These data confirm cell-autonomous effects of Eng deletion and show that ENG and ALK1 function in opposite ways in regulating sprouting angiogenesis, despite similar AVM phenotypes following Eng and ALK1 LOF 16, 25 . Taken together, this suggests that sprouting angiogenesis and AVM in HHT result from different mechanisms and that these biological phenomena are not functionally linked.
Eng LOF ECs in angiogenic sprouts ex vivo display reduced migratory capacity
To elucidate the impact of ENG on EC behaviour and VEGFA-driven EC responses in the absence of potential systemic effects, we studied sprouting angiogenesis in aortic explant cultures with or without VEGFA ( Fig. 3a) , utilizing time-lapse microscopy. EC tracking was facilitated by an endogenous conditional nuclear-localized fluorophore in either control or Eng LOF mice (Eng wt/wt :Cdh5(PAC)CreER T 2 : R26R-H2B-mCherry or Eng flox/flox :Cdh5(PAC)CreER T 2 :R26R-H2B-mCherry) ( Supplementary Fig. 4 ). Following recombination, EC nuclei were tracked by fluorescence microscopy ( Fig. 3b and Supplementary Video 1). There was no effect on sprout elongation but an increase in sprout diameter in Eng LOF cultures ( Fig. 3c,d ). In addition Eng LOF ECs showed reduced migration velocity, compared with controls, both with and without VEGFA ( Fig. 3e ). Nevertheless, VEGFA significantly increased sprout elongation and migration speed of Eng LOF ECs ( Fig. 3c,e ). During angiogenesis, ECs migrate towards the tip (anterograde), stay still, or move away from the tip (retrograde) 26, 28 . Here, VEGFA treatment promoted anterograde migration of both WT and Eng LOF ECs ( Fig. 3f,g) . Also, Eng LOF ECs stayed still for a longer time than WT cells ( Fig. 3h ).
Taken together, the data indicate that VEGFA promotes migration and sprouting of ECs, in a partly ENG-dependent manner, in support of the idea that ENG promotes angiogenesis cell-autonomously. 
AVM expansion, but not initiation, involves Eng LOF-mediated proliferation
The retinal vasculature of Eng LOF mice has been reported to be hyper proliferative, but information on spatial differences, potential cellautonomous effects, and involvement in AVM formation is missing 14 .
To investigate this, we induced mosaic Eng deletion at P1, utilizing conditional nuclear-mCherry expression to identify recombined ECs. EdU (5-ethynyl-2-deoxyuridine) injection at P7, and co-staining for the EC-specific transcription factor ERG1 revealed an increase in proliferation of Eng LOF cells compared with WT cells in mosaic but phenotypically normal vessels (non-AVM) of the brain (Fig. 4a,b,d) .
In mosaic AVM-like structures Eng LOF EC proliferation was further increased, here accompanied by increased WT cell proliferation ( Fig. 4c,d ). Note that in these brains VEGFA was increased ( Fig. 1d ). A similar analysis was performed in retinas in which arteries, veins and capillaries could be identified on the basis of morphological criteria. With low degree of recombination and no AVMs, proliferation was similar between Eng LOF and non-recombined ECs and also not Supplementary Table 1 . different from ECs in control retinas ( Fig. 4e ). However, in retinas with a higher recombination rate and with AVMs, Eng LOF ECs showed a higher degree of proliferation compared with non-recombined ECs, in vessels outside of the AVMs (Fig. 4e ). Within AVMs both cell populations displayed an equal increase in proliferation ( Fig. 4e ). We then analysed general proliferation of retinal ECs specifically in arteries, veins and capillaries and found no change in proliferation in retinas without AVMs ( Fig. 4f ,g). In retinas with AVM however, proliferation was specifically increased in arteries as well as in AVMs. Altogether these analyses indicate that ENG is not a major player in regulation of proliferation in normal development, or during the initiation of AVM, but that Eng deletion promotes cell-autonomous proliferation following disturbed vessel function, potentially relating to increased VEGFA levels. The equal increase in proliferation of Eng LOF and WT ECs in mosaic retinal AVMs indicates however that AVM expansion involves additional mechanisms to those directly induced by Eng deletion.
Eng deletion disrupts arteriovenous EC distribution causing arteriole-derived AVM
To elucidate the importance of ENG for vascular patterning, remodelling and potential role in migration in vivo, we induced mosaic EC-specific deletion of Eng and analysed the localization of recombined YFP-positive cells in the retinal vasculature. In control mice, carrying the conditional YFP reporter, recombined cells distributed evenly throughout the vasculature 6 days post recombination ( Fig. 5a,e ). In mosaic Eng i∆EC mice however, recombined ECs (Eng LOF) were found enriched in the main veins compared with 'near-venous' regions, arteries and 'near-artery' regions ( Fig. 5b,f) . In contrast, following mosaic recombination in Eng iECOE mice, Eng OE cells showed preferential location to arteries ( Fig. 5c,g) . To investigate the impact of differential ENG expression on arteriovenous sorting, we analysed cellular distribution of hENG OE cells in the background of complete Eng deletion using the Eng i∆EC+iOE mice. In this scenario, veins and AVMs were devoid of hENG OE cells, which accumulated in arteries ( Fig. 5d ,h). Only in the case of near complete induction of hENG overexpression in Eng i∆EC+iOE mice, the AVM phenotype was rescued ( Supplementary  Fig. 5a ). Together these experiments designate ENG as a key protein balancing the distribution of ECs to the arterial or venous regions within the developing vasculature.
To determine the anatomical origin of AVMs, mosaic Eng deletion (Eng i∆EC ) was induced at P4 and the retinal vasculature analysed at P7. Three days following deletion, arterioles with high recombination were frequently enlarged suggestive of AVM initiation ( Fig. 5i ). After six days, malformations were more frequent and pronounced within arterioles, displaying accumulation of recombined cells (Fig. 5i,j) . To investigate the successive development of AVMs from the early arteriole-specific malformations, Eng i∆EC mice were induced at P4 and analysed at P6, 7, 8 and 10. These analyses suggest that enlarged arterioles gradually expand to the adjacent veins to establish the AV shunts ( Supplementary Fig. 5b ). AVMs acquired venous characteristics as indicated by the venous-typical pattern of smooth muscle cell coverage and reduced DLL4 expression ( Supplementary Fig. 5b ,c). These data provide evidence for an arteriolar origin of ENG-related AVMs, which are primarily initialized by regional accumulation of Eng LOF cells possibly as a consequence of their reduced ability of migrating against the direction of flow. However, clonal analysis of the mosaic retinal vasculature of Eng flox/flox :Cdh5(PAC)CreER T 2 :R26R-H2B-mCherry mice revealed an equal relative contribution of WT and Eng LOF ECs (mCherry + ) to established AVMs and the complete vasculature ( Fig. 5k,l) , suggesting non-cell-autonomous mechanisms contributing to the expansion of AVMs.
ENG promotes flow-mediated directional upstream migration of ECs
During vascular development ECs have been reported to polarize and migrate in a manner dependent on flow direction and magnitude 2, 26, [29] [30] [31] [32] . It has also been shown that arteries are formed by migration of ECs from veins 30 . The specific localization of Eng LOF and Eng OE ECs in the mosaic retinal vasculature may relate to alterations in flow-mediated migration. To this end, fully confluent WT or ENG knockdown (lentiviral-mediated short hairpin RNA (shRNA)) human dermal microvascular endothelial cells (HDMECs), were subjected to laminar flow and imaged by time-lapse microscopy ( Fig. 6a and Supplementary Videos 2 and 3). Tracking of cell migration showed no difference in overall migratory distance ( Fig. 6b ). Whereas the majority of control cells moved against flow, the majority of ENG knockdown cells instead migrated with the flow (Fig. 6c,d ). Isolated lung ECs from P7 Eng i∆EC and control mice recapitulated this behaviour. In addition, ENG OE ECs from Eng iECOE mice showed enhanced migration against flow, altogether indicating that ENG promotes flow-regulated migration in a dose-dependent manner (Fig. 6e ). The effects were not due to major alterations in classical shear-stress-regulated genes as WT and ENG knockdown ECs responded to shear stress by the expected upregulation of KLF2 and JAG1 ( Fig. 6f-h ). However, HEY1 was downregulated by flow in control cells but not in ENG knockdown cells, in which HEY1 was already lower in the no-flow state (Fig. 6i ). To investigate whether Eng LOF may affect flow-induced polarization in vivo, positioning of the Golgi apparatuses relative to their respective nuclei and flow direction was analysed in arterioles of postnatal retinas. As expected ECs of WT mice regularly polarized against flow direction 32 ( Supplementary  Fig. 6a,d ). However, with mosaic Eng LOF, the fraction of cells showing altered polarization was increased within Eng LOF cells compared with WT ( Supplementary Fig. 6b,e ). In AVMs, both WT and LOF cells were abnormally polarized ( Supplementary Fig. 6c ,f), again suggesting a non-cell-autonomous effect during growth of established AVMs.
To study the effect of ENG on flow-regulated migration in vivo, we performed in vivo imaging to track individual ECs within remodelling vessels of wounded corneas of Eng i∆EC and control mice. Induced YFP expression (mosaic recombination) permitted identification and tracking of individual ECs ( Fig. 6j and Supplementary Video 4). Out of the trackable motile ECs in control mice 72% migrated towards the flow direction, compared with only 39% in Eng LOF mice ( Fig. 6k,l) .
ENG deletion alters VEGFA-induced VEGFR2 kinetics and downstream signalling
A line of in vivo experimental data indicates that the establishment of AVMs in adult Eng heterozygote or Eng LOF mice is triggered by the presence of VEGFA 19, 20 . In spite of this, no obvious differences in VEGFR2 phosphorylation or its downstream signalling components have been reported 33 
In AVM All vasc. tyrosine phosphorylation of VEGFR2 (Fig. 7a,b ). However, ENG knockdown cells exhibited a reduced time-dependent decrease of total VEGFR2 following VEGFA stimulation compared with control ( Fig. 7c,d ). In addition shENG ECs displayed enhanced activation of the VEGFR2 downstream kinase AKT while ERK1/2 activation was not affected ( Fig. 7e-g) . This suggests a differential activation of VEGFR2 downstream pathways, dependent on ENG.
To specifically study VEGFR2 at the plasma membrane (that is, glycosylated VEGFR2) the membrane protein fraction was isolated utilizing cell surface biotinylation. VEGFA treatment induced a gradual clearance of VEGFR2 from the membrane in control and shENG ECs but the latter displayed a slightly altered VEGFR2 internalization kinetics. Whereas VEGFR2 continued to decrease from 30-60 min in the WT, no further reduction was seen in ENG knockdown cells (Fig. 7h,i) , suggesting an increased recycling of VEGFR2 to the plasma membrane in shENG ECs. No significant difference in phosphorylation of membrane-located VEGFR2 was observed, in line with our data from whole-cell lysates (Fig. 7h,j) . Furthermore, immunostaining for VEGFR2 and ENG showed co-localization in subsets of cytoplasmic vesicles of VEGFA-treated HDMECs (Fig. 7k ) as well as in ECs of P7 mouse brains ( Supplementary Fig. 7a ). Co-localization of VEGFR2 and ENG was frequently found in EEA1-, Rab5-or Rab7-positive endosomes while rarely in endoplasmic reticulum, suggesting potential physical interaction between VEGFR2 and ENG, at least during intracellular trafficking and endosomal sorting ( Supplementary Fig. 7b ). However, to resolve the precise role of ENG on VEGFR2 trafficking would require further investigation.
Inhibition of VEGFR2 or PI(3)K signalling reduces the severity of Eng LOF-mediated AVM
To test the relevance of altered VEGFR2 activity and downstream signalling on the development of AVM in vivo, the VEGFR2 kinase inhibitor SU5416 or the phosphoinositide 3-kinase (PI(3)K)-AKT inhibitor wortmannin was administered daily (P4-6) to Eng LOF pups (LOF induced at P3). Both treatments tended to reduce the frequency of AVMs in Eng LOF pups and significantly reduced the severity of the AVMs as indicated by less distorted vascular morphology and smaller diameters of the AV shunts in P7 retinas (Fig. 8a-c) . To investigate the respective drugs' effects on flowmediated cell behaviour, ECs exposed to flow were treated and liveimaged as described above (Fig. 6a ). The general migration speeds of both control and ENG knockdown cells were slightly reduced by either SU5416 or wortmannin ( Supplementary Fig. 8a ). SU5416 inhibited flow-directed upstream migration of control cells as well as downstream displacement of shENG ECs, indicating the requirement for VEGFR2 signalling in EC migration. Interestingly, wortmannin did not alter upstream migration of control ECs but inhibited downstream migration of shENG ECs ( Supplementary Fig. 8b ).
In conclusion, we demonstrate that ENG knockdown has no effect on VEGFR2 activation, but alters VEGFA-induced VEGFR2 kinetics. This probably contributes to the observed enhanced AKT phosphorylation in the absence of ENG and may consequently feed into the development of AVMs in vivo. In accordance, drugmediated blockage of VEGFR2 or AKT in Eng LOF mice reduced AVM severity.
DISCUSSION
ENG or ALK1 LOF mutations lead to faulty regulation of processes normally involved in angiogenesis and vascular homeostasis and play a central role in the formation of AVMs. However, the sequence of events during the formation, and the origin of the malformation are incompletely resolved.
Here we show that Eng LOF cells are unable to follow instructive migratory cues provided by the direction of blood flow, in turn leading to local accumulation of Eng LOF cells and consequential AVM, expanding from arterioles (summarized in Fig. 8d ). Furthermore, Eng LOF alters VEGFR2 kinetics and promotes downstream AKT signalling in response to VEGFA stimulation, providing mechanistic understanding of reduced AVM expansion following VEGFR2 inhibition. In agreement with previous studies 34, 35 we demonstrate the effectiveness of either VEGFR2 or PI(3)K/AKT inhibition, here in Eng LOF mice, strengthening the hypothesis for the coupling of VEGFA/VEGFR2 signalling to the formation of AVM in HHT.
Although ENG and ALK1 are intimately connected our data suggest an opposing effect of ENG to that reported for ALK1 on tip/stalk cell selection. Whereas Eng LOF results in reduced tip-cell potential, Alk1 LOF provides a cell-autonomous tip-cell advantage, and hypersprouting phenotype 16, 25 . This indicates that ENG is not required for tip-cell selection per se. ENG OE on the other hand leads to a strong over-representation of ENG OE cells in the tip-cell position, suggesting that ENG augments the ability to take, or maintain, the tip-cell position. Despite the impact of ENG on tip-cell capacity, neither Eng LOF nor OE strongly affected the overall sprouting. Only when Eng LOF causes large AVMs and hypoxia, hypersprouting is observed 16 . Together, these data show that tip-stalk selection is not directly related to initiation of AVMs in HHT.
Several studies have illustrated that ECs migrate against flow, but the importance of this in vascular patterning has not been exposed 2, 26, [29] [30] [31] [32] . Here we show that ENG controls flow-directed migration in a dose-dependent manner, and is required for correct vascular morphogenesis. The strong selective enrichment of Eng LOF ECs in veins and ENG OE ECs in main arteries uncovers ENG as a potent regulator of artery-vein specification. Analysis of mosaic Eng LOF retinal vasculature reveals that AVMs predominantly arise from arterioles. This, together with strong Eng expression in arterioles of adult mice, highlights the importance of ENG in these specific regions. During development the formation of arterioles involves a thinning of the previous immature structure, often coinciding with a reduction in number of ECs 36 . The lack of EC apoptosis during this period of development suggests that cell exclusion normally occurs by migration 32 . Hence, the sporadic accumulation of Eng LOF cells within expanding arterioles infers a locally reduced ability of ECs to escape the remodelling arterial structure by flow-mediated directional migration. Instead the retention of Eng LOF cells causes vessel expansion and AVM development. This notion is strengthened by previous transcriptional and gene-ontology analyses of isolated ECs from HHT1 patients that imply reduced angiogenesis and EC migration 37 .
To what extent the ENG-dependent flow-induced cellular behaviour relies on the ENG-mediated increase in flow sensitivity to BMPmediated SMAD phosphorylation remains unknown 38 . Interestingly, AVM establishment in Alk1-deficient zebrafish was shown to require flow and suggested to involve aberrant migratory behaviour 36, 39 . The red or green dashed line indicates a comparison between 10 and 60 min for the control or shENG cells, respectively. n = 3 independent experiments. P = 0.003 (shControl) between 10 and 60 min, two-tailed unpaired t-test. (j) Phosphorylated VEGFR2 within the cell membrane was detected with p * Y and ratios of phosphorylated/total VEGFR2 at different time points were plotted. n = 3 independent experiments. No difference between shControl and shENG, twoway ANOVA. (k) Co-staining for VEGFR2 (red) and ENG (green) in HDMECs treated with VEGF (50 ng ml −1 ) for 10 min. VEGFR2 and ENG co-localize in subsets of intracellular vesicles (indicated by arrows and the dashed line box).
The arrowheads indicate non-co-localizing VEGFR2 or ENG. Co-localization of signals within the boxed region was analysed by Volocity. Images are representative of 3 independent experiments. Scale bars, 10 µm (whole pictures); 1 µm (boxed areas). Unprocessed scans of the blots shown in a,c,e,h are provided in Supplementary Fig. 9 . All values are mean ± s.e.m. Statistics source data are shown in Supplementary Table 1 . a.u., arbitrary units. Our data demonstrate ENG-mediated regulation of VEGFR2 signalling, providing potential mechanistic understanding of AVM development in Eng LOF and in HHT1 patients. We show ENG and VEGFR2 co-localization in intracellular vesicles, and an effect of ENG on VEGFR2 kinetics after VEGFA stimulation, probably causing augmented AKT activation.
Modulating intracellular trafficking and recycling of VEGFR2 has been demonstrated to affect the balance between proliferation and migration, in response to VEGFA stimulation, thereby presenting similarities to signalling and behaviour of the Eng LOF ECs 40 . Although this exemplifies the power of alternative VEGFR2 trafficking to favour proliferation or migration, the determining mechanisms remain elusive. We observed that the AVM phenotype in ENG LOF postnatal retinas was relieved by inhibition of VEGFR2 or AKT. Similar results in Alk1 LOF mice indicate that AKT activity plays an important role in AVM also in HHT2 (ref. 34) . Interestingly, Alk1 deletion causes also Eng downregulation, adding to the complexity of mechanistic contributions of Alk1 and Eng in HHT 15 . Furthermore, previous studies demonstrated that AKT phosphorylation promotes venous differentiation at the expense of arteriogenesis, an observation that supports our findings in HHT1 (ref. 41 ).
Siekmann and colleagues 42 report that loss of functional ENG in zebrafish leads to arteriovenous shunting between the dorsal aorta and the cardinal vein. The primary defect in this case appears to be enlarged ECs associated with failure of EC alignment within the vessel in response to flow. Similar to our data, altered EC numbers/proliferation seemed not to contribute to the initiation of AVMs, but blood flow had major effects on endothelial behaviour in the absence of ENG. While EC responses to blood flow in vivo are not yet fully understood, it is clear that ENG is important for regulating EC shape and migration in ways that are essential to acquire and maintain normal vascular hierarchy.
Vascular malformations are diverse in both aetiology and manifestation, and compose a large clinical problem. The cellular mechanisms underlying the formation of AVM in HHT1, such as misguided migration as described here, may also apply to other hereditary or sporadic vascular diseases. We demonstrate direct connections between ENG and VEGFR2 biology, providing an exciting basis for drug targeting of the VEGFA/VEGFR2/AKT signalling system in HHT1.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper.
Note: Supplementary Information is available in the online version of the paper METHODS Mice. Eng flox/flox mice 43 were crossed with Cdh5(PAC)-CreER T2 mice 44 to generate endothelial specific inducible Eng knockout. These mice were in turn crossed with transgenic fluorescent reporter mouse lines B6.Cg-Gt(ROSA)26Sor tm3(CAG−EYFP)Hze /J (stock number 007903, The Jackson Laboratory) or R26R-H2B-mCherry (Acc. no.
[CDB0203K], http://www.cdb.riken.jp/arg/reporter_mice.html) 45 allowing for in vivo lineage tracing and ex vivo time-lapse imaging. For isolation of brain ECs, such mice were crossed with Claudin5-eGFP mice (generated by B. Lavina and C.B., unpublished) that specifically express GFP in ECs. For induced gene knockout in neonatal mice, tamoxifen was administrated by postnatal intraperitoneal injections. Eng full knockout mice (Eng lacZ/lacZ ) were generated in collaboration with Regeneron by targeted insertion of the lacZ gene into exon 2 of Eng. TgENG LoxP mice 46 were crossed with Cdh5(PAC)-CreER T 2 mice to generate endothelial specific inducible ENG overexpression. The ENG overexpression mice were then crossed with Eng flox/flox to generate Eng i∆EC+iOE mice. Both males and females are included. Animal housing and procedures were in accordance with Swedish legislation and approved by the local animal ethics committees.
Tamoxifen administration. Tamoxifen (10 or 50 µg) was administrated by intraperitoneal (i.p.) injection at postnatal day (P) 1 or 4 to induce nearly complete gene knockout in neonatal mice. For mosaic Eng knockout, 3-10 µg of tamoxifen was administrated by i.p. injection at the indicated time point. For mosaic ENG overexpression in Eng iECOE or Eng i∆EC+iOE mice, 100 µg of tamoxifen was administrated by i.p. injection at P3.
In vivo imaging and quantification of EC migration. Mice received tamoxifen (0.2-1 mg) one week prior to cornea suture implantation. The cornea suture method was performed as previously described 47 . In brief, mice were anaesthetized and 3 sutures of Nylon surgical silk (11-0, AROSurgical) were implanted per cornea (considered day 0). At days 5-7, mice were anaesthetized and the newly formed vasculature of the corneas was imaged utilizing a Leica SP8 microscope (Leica Microsystems) with a 25×/1.0 objective. Z-stacks of epifluorescence images were acquired every 24 h. Time-lapse bright-field images were acquired to record blood flow direction. Displacement of ECs between two imaging time points were defined by the distance to a selected reference point (adjacent vessel branches, or cells without relative change of distance to their neighbouring cells within 24 h) using LAS AF built-in modules.
In vivo VEGFR2 or AKT inhibition. The mice (Eng flox/flox ; Cdh5(PAC)-CreER T2 ) were injected with tamoxifen (50 µg) at P3 followed by i.p. injection of SU5416 (20 mg kg −1 day −1 , Sigma) or wortmannin (0.3 mg kg −1 day −1 , Sigma) from P4-P6. The same volume of dimethylsulfoxide (DMSO) was injected to corresponding genotypes, serving as controls. Mice were euthanized at P7 and retinas processed for immunofluorescent analysis.
Analysis of tip-cell competence within retinal or brain vasculature of P7 mice.
Retinas or brains with 15-90% recombination were used for the quantification. Contributions of recombined (YFP + ) or non-recombined (YFP − ) cells to tip-cell position were calculated as number of YFP + tip cells/(YFP + /CD31 + area) and number of YFP − tip cells/(YFP − /CD31 + area) followed by calculation of the ratio of the two for each sample. Tip cells in five different regions covering both cerebral cortex and striatum were counted and summed for each brain.
Analysis of distribution of recombined cells in the retina.
Mosaic recombination was induced at P1 by tamoxifen. Retinas were taken at P7 and stained for CD31, YFP and human ENG and flat mounted to slides by cutting into 4 leaflets. Images of whole retinas were taken by z-stack tile scanning with a confocal microscope (Leica SP8). For each leaflet, general recombination ratio for Eng knockout was measured as YFP + area/CD31 + area in Volocity; recombination ratio for Eng overexpression was measured as human ENG + area/CD31 + area. Arteries and veins were identified using several well-established criteria, as follows. Arteries have smaller diameter, fewer branches and higher smooth muscle cell coverage than veins. Also, arteries and veins appear in an alternating pattern in the retina. Areas within approximately 50 µm around the main arteries and veins are defined as A and V regions respectively. Areas beyond these regions until capillary are defined as Vessels near A or Vessels near V regions. Regional recombination ratio was also measured in the same way as general recombination. The ratio of regional/total recombination was used to assess the distribution of recombined cells.
Analysis of anatomical localization of malformation initiation.
Mosaic recombination was induced at P4 by tamoxifen. Retinas were taken at P7 and stained for CD31 and αSMA and mounted for imaging. Images of whole retinas were acquired by z-stack tile scanning with a confocal microscope. A site of malformation was scored positive if the diameter of the vessel exceeded its respective feeding (arterioles, capillaries) or draining (venules, capillaries) vessel.
Hypoxia detection in mouse retina. Hypoxia in the retina was assessed by i.p. injection of 60 mg kg −1 of pimonidazole (Hypoxyprobe) to P7 mice 90 min before euthanization. Eyes were fixed in 4% paraformaldehyde (PFA) for 2 h at room temperature. Retinas were isolated and immunostained for CD31 and pimonidazole adducts.
Aortic ring assay. Thoracic aortas were taken from mice at P7 and cut into 1 mm rings after removal of the connective tissues. The rings were embedded between two layers of rat tail collagen, type I (Life Technologies) and cultivated in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and VEGFA (Peprotech, 30 ng ml −1 ). For growth factor treatment, medium was changed to DMEM with 2% BSA and with or without the inclusion of VEGFA (30 ng ml −1 ) after 4 days of initial cultivation. Samples were fixed in 4% PFA and analysed by microscopy after immunostaining with antibodies.
Live imaging and cell tracking in angiogenic sprouts of aortic rings. Aortic rings were cultured as described above in 24-well glass-bottom plates (Mattek) and imaged from day four using a Leica SP8 laser confocal microscope system (Leica Microsystems; equipped with a motorized stage and a CO 2 incubator) maintained at 37 • C and 5% CO 2 with a humidifier. Twenty-nine Z slices were acquired at each position every 20 min. Medium was changed every day until termination. Cellular migration was analysed using MTrackJ in ImageJ (NIH) and Imaris software (Bitplane). Single-cell tracks were selected manually and data were collected for quantitative analysis of sprout elongation, cellular migration speed and directionality. Distances of the nuclei at the tip position from the first to the last time points were measured as elongation of sprouts. Migration speed of one cell was obtained by averaging the transient speed at each time point (measured by the software). The relative number of time points a cell migrated towards the sprouting direction is defined as anterograde migration and analogous for retrograde migration. A cell that migrated less than 2 µm between two time points was defined 'still' . A total of 17-38 cells were measured for each genotype or treatment. Statistics were analysed using Prism 5.0 software (GraphPad).
Cell culture. HDMECs (PromoCell) were cultured in endothelial cell growth medium MV2 with supplied supplements (PromoCell). The cell lines were authenticated by the vendor (Promocell) for cell morphology and cell-type-specific markers using flow cytometric analyses. The cell lines were not authenticated thereafter. The cell lines were tested for mycoplasma contamination by the vendor (Promocell). The cell lines were not tested for mycoplasma contamination thereafter. No cell lines used in this study are found in the database of commonly misidentified cell lines (ICLAC and NCBI Biosample). For VEGFA stimulation, sub-confluent cells were starved in MV2 with 0.2% FBS without supplements for 5 h. The same medium with VEGFA (50 ng ml −1 ) was then added to the cells and incubated at 37 • C. Cells were lysed at the indicated time points for total or membrane protein isolation or fixed immediately in 4% PFA for antibody staining.
Isolation of mouse lung ECs. Isolation of ECs from mouse lung was done by using anti-CD31-antibody (BD Pharmingen)-conjugated Dynabeads (Life Technologies) as previously described 48 . Cells were cultured in MV2 medium (PromoCell) with 4-OH-tamoxifen (5 µM, Sigma) for 5 days before splitting for experiments.
Flow-mediated behavioural analysis. HDMECs or mouse lung ECs were seeded at fully confluent densities in a flow chamber (CellDirector 2D, Gradientech) and cultured in an incubator for 3 h before the experiment. The chamber was then connected to a syringe pump and placed on a microscope (equipped with cell culture system) for imaging. Pre-warmed endothelial cell growth medium MV2 was pumped through the flow chamber with a flow rate of 150 µ l min −1 (7.5 dyne cm −2 ). For VEGFR2 or AKT inhibition SU5416 (5 µM) or wortmannin (100 nM) was added to the medium. Bright-field images were taken every 5 min for 5 h. Cellular migration was analysed using MTrackJ in ImageJ.
RNA interference.
Lentivirus was used to introduce specific short hairpin RNAs (shRNAs) into HDMECs. The lentiviral vector pLKO.1-TRC was a gift from D. Root (Broad Institute, USA, Addgene plasmid no. 10878). The oligonucleotide sequences used to target human ENG were selected from the MISSION shRNA library (TRCN0000083142, Sigma). The control shRNA sequence lacks targets (5 -CCTAAGGTTAAGTCGCCCTCG-3 ) (Addgene, plasmid no. 1864). Lentiviruses were generated using the packaging cell line 293FT. Supernatants containing viral particles were collected at 48 and 72 h after transfection. Viral supernatants were diluted 1:5 and supplemented with Polybrene (8 µg ml −1 ) for infection of HDMECs. The virus-containing medium was replaced with fresh medium 24 h after infection. The cells were selected by puromycin (1 µg ml −1 ) for 7 days and then split for experiments.
Immunofluorescence. Mice were euthanized and brains and eyes immediately removed and fixed in 4% PFA. Brain coronal sections (200 µm thickness) were generated using a vibratome. Retinas were dissected and processed for whole-mount antibody staining. Samples were incubated in phosphate-buffered saline (PBS) with 0.5% Triton X-100 and 1% BSA for 3 h at room temperature and then with primary antibodies in the same solution overnight at 4 • C with agitation. After 3 washes at room temperature, samples were incubated with secondary antibodies overnight at 4 • C, washed 3 times and mounted to slides for imaging.
For staining of cell lines, cells were cultured on coverslips and fixed in 4% PFA after treatment. After fixation, the cells were washed 3 times in PBS and permeabilized in PBS with 0.1% Triton X-100 for 5 min, followed by blocking in 1% BSA for 30 min and incubation with primary antibodies overnight at 4 • C. Cells were washed 3 times in 0.1% Triton X-100 and incubated with secondary antibodies for 1 h at room temperature. They were then washed 3 times and mounted to slides for imaging. Specimens were imaged by LSM 700 (Carl Zeiss AG) or Leica SP8 (Leica Microsystems) laser confocal microscopes. Image processing and analysis was done using Volocity (PerkinElmer) and ImageJ software.
Antibodies: mouse anti α-smooth muscle actin (ASMA) (clone: 1A4) (C6198, Sigma, 1:100); goat anti-mouse CD31 (AF3628, R&D Systems, 1:500); rat anti-Endoglin (clone: MJ7/18) (14-1051, eBioscience, 1:400); chicken anti-GFP (ab13970, Abcam, 1:1,000); rabbit anti-ERG (clone: EPR3864) (ab92513, Abcam, 1:500); rabbit anti-VEGFR2 (clone: 55B11) (2479, Cell Signaling, 1:200); goat anti-VEGFR2 (AF357, R&D Systems, 1:200); mouse anti-human Endoglin (clone: SN6) (14-1057-82, eBiosciences, 1:200); goat anti-human Endoglin (AF1097, R&D systems, 1:500); alexa555-mouse anti-GM130 (clone: 35/GM130) (560066, BD, 1:200); mouse anti-EEA1 (clone: mAbcam18175) (ab18175, Abcam, 1:500); rabbit anti-Rab5 (clone: C8B1) (3547S, Cell Signaling, 1:200); rabbit anti-Rab7 (clone: D95F2) (9367S, Cell Signaling, 1:200); goat anti-Calnexin (sc-6465, Santa Cruz, 1:200). Secondary antibodies conjugated with Alexa Fluor dyes were obtained from Life Technologies or Jackson ImmunoResearch Laboratories.
were similar between the groups compared. Differences were considered significant with a P < 0.05. For animal experiments, no statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiment and outcome assessment. Data availability. Source data for figures 1d, 2g,m, 4d, 6f-i and 7b,d,f,g,i,j have been provided as Supplementary Table 1 . All other data supporting the findings of this study are available from the corresponding author on request.
In the format provided by the authors and unedited. Supplementary Figure 1 Supplementary Figure 8 Effects of VEGFR2 or PI3K inhibition on migration of ECs exposed to flow. (a) Migration speed of control or ENG knockdown HDMECs under flow, untreated (data derive from sets in Fig. 6b ), treated with SU5416 or Wortmannin was measured by MtrackJ in ImageJ. Control, shControl, n=295 cells; shENG, n=287 cells. SU5416, shControl, n=103 cells; shENG, n=108 cells. Wortmannin, shControl, n=100 cells; shENG, n=105 cells. shControl, P<0.001 (SU5416); P=0.006 (Wortmannin). shENG, P<0.001 (both treatments). (b) The displacement of HDMECs migration towards direction of flow (Y axis) untreated (data derive from data sets in Fig. 6b ), under the treatment of SU5416 or Wortmannin. Control, shControl, n=295 cells; shENG, n=287 cells. SU5416, shControl, n=103 cells; shENG, n=108 cells. Wortmannin, shControl, n=100 cells; shENG, n=105 cells, from one series of experiments. shControl, P=0.01 (SU5416). shENG, P<0.001 (both treatments). Values are population mean ± S.E.M. N.S.= not significant. P values in (a, b) indicate difference to the untreated control of the same genotype, two-tailed unpaired t-test. Supplementary Figure 9 Unprocessed scans of western blots. The whole membranes exposed for the detection of protein bands shown in Figure 7 (a, c, e, h) are displayed in (a), (b), (c), (d), respectively.
